Selecting the correct on label or off label medication to treat obesity can be confusing. The acronym RXAOM provides a framework for individualizing the selection process. RXAOM stands for Reimbursement/cost, eXcluded, Additional reasons, Off-label option, Medication selection – shared decision. This presentation will use case studies from the presenters obesity practice to demonstrate using this process and making individualized selections. CME/CE Expiration Date: 10/29/26 *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation. Learning Objectives Evaluate evidence-based guidelines for pharmacologic management of chronic disease of obesity Identify available pharmacotherapeutics both on and off label that can be utilized to support treatment of chronic disease of obesity. Utilize the RXAOM process to make individualized medication selection through case studies.
- Provider:Obesity Medicine Association
- Activity Link: https://academy.obesitymedicine.org/node/5508
- Start Date: 2023-10-27 05:00:00
- End Date: 2023-10-27 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all